Identifying and managing pain in children is a vital role for pharmacists.
Commonly encountered paediatric pain can be categorised as pain associated with infection...
A recent study of coronial inquest findings revealed medicines relating to mental health conditions (antidepressants, antipsychotics) were most commonly implicated in non-opioid and non-benzodiazepine...
The Therapeutic Goods Administration (TGA) has made an interim decision to upschedule modified release (MR) paracetamol tablets from 1 October 2019 due to safety...
In the third of a six-part series, we expand on the PSA Choosing Wisely recommendations, taking a closer look at the use of sedatives....
The Pharmaceutical Benefits Scheme (PBS) recently made changes to the listings for proton pump inhibitors (PPIs) in an effort to address overprescribing.
The changes, which...
In the fourth of a six-part series, we expand on the PSA Choosing Wisely recommendations, taking a closer look at the dispensing of repeat...
Treating bacterial infections without antibiotics might sound like a problem from another time, but it is a challenge that healthcare professionals in remote areas...
The evidence is in: positive health outcomes can hinge on patients’ ability to understand health information – and on pharmacists’ ability to impart it.
Health...
Research highlights the vital role HMRs play in averting medicine misadventure.
In 2016, members of the PSA Accredited Pharmacist Leadership Group (APLG) undertook an...
A recent study from the University of South Australia has highlighted the significant number of patients at risk of developing opioid dependence post-surgery, calling...
